The Prediction Markets

Market comparison

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

1 venue · 5 outcome rows · 0 comparable lines · 0 verified parity · active

Kalshi

Open venue ↗

5 outcomes · $24K reported volume

Observed 3m ago

Recorded venue end date: Jan 1, 2028

Check settlement rules before comparing contracts. Matched outcomes may settle differently. These are stored prices; record update times do not certify live quotes. Differences exclude fees and available size.

No shared outcome identities or comparable outcome lines are available for this event. Each venue’s outcomes are listed separately.

Before 2028

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

92.0%

Bid 84.0% · Ask 92.0%

Before 2028

Open Kalshi ↗

Before Jan 1, 2027

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

22.0%

Bid 22.0% · Ask 23.0%

Before Jan 1, 2027

Open Kalshi ↗

Before July 2027

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

86.0%

Bid 84.0% · Ask 86.0%

Before July 2027

Open Kalshi ↗

Before Mar 1, 2027

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

65.0%

Bid 58.0% · Ask 65.0%

Before Mar 1, 2027

Open Kalshi ↗

Before October 2027

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

83.0%

Bid 81.0% · Ask 88.0%

Before October 2027

Open Kalshi ↗

Prices are shown as percentages of a $1 payout. “pp” means percentage points. A dash means data is unavailable.

View event details, charts and rules →Explore more markets